Epigral Limited — Others, 27-01-2025: Statement of deviation(s) or variation(s) under Reg. 32

Epigral Limited has announced a board meeting to confirm that there is no deviation in the utilization of Rs. 333.05 Crores raised through its Qualified Institutional Placement. This confirmation was reviewed by the Audit Committee, with funds allocated primarily for loan repayments, capital expenditures, and general corporate purposes, all aligned with original objectives. The lack of deviations indicates effective management of resources, likely enhancing investor confidence. This update reflects a disciplined approach to capital use, which could lead to a positive outlook for the company's financial health moving forward.